Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Reactive arthritis.

A Toivanen1, P Toivanen

  • 1Department of Medicine, Turku University, Finland. paavo.toivanen@utu.fi

Current Opinion in Rheumatology
|July 26, 2000
PubMed
Summary
This summary is machine-generated.

Reactive arthritis (ReA) research saw no major breakthroughs this year. Diagnostic criteria are crucial, and antibiotics may help Chlamydia-triggered ReA cases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction to: Remarkable improvement in serum 25-hydroxyvitamin levels among hip fracture patients over a 12-year period: a prospective study in South-eastern Finland.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2018
Same author

Remarkable improvement in serum 25-hydroxyvitamin levels among hip fracture patients over a 12-year period: a prospective study in South-eastern Finland.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2017
Same author

Ankylosing spondylitis: current approaches to treatment.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy·2007
Same author

Association of tumour necrosis factor a, b and c microsatellite polymorphisms with clinical disease activity and induction of remission in early rheumatoid arthritis.

Clinical and experimental rheumatology·2007
Same author

Sindbis viruses and other alphaviruses as cause of human arthritic disease.

Journal of internal medicine·2004
Same author

HLA-DR-DQ haplotypes and genotypes in Finnish patients with rheumatoid arthritis.

Annals of the rheumatic diseases·2004
Same journal

New approaches to the management of cutaneous lupus.

Current opinion in rheumatology·2026
Same journal

"Updates in chronic nonbacterial osteomyelitis: emerging insights across the age spectrum".

Current opinion in rheumatology·2026
Same journal

Difficult-to-treat, complex-to-manage, treatment-refractory spondyloarthritis: semantics or substance?

Current opinion in rheumatology·2026
Same journal

Update on IgA nephropathy: implications for treatment in IgA vasculitis: a guide for rheumatologists.

Current opinion in rheumatology·2026
Same journal

Polyarticular juvenile idiopathic arthritis: insights from genetic studies on disease risk and pathogenesis.

Current opinion in rheumatology·2026
Same journal

Immune dysregulation in children with Down syndrome: clinical implications and emerging therapies.

Current opinion in rheumatology·2026
See all related articles

Area of Science:

  • Rheumatology
  • Immunology
  • Microbiology

Background:

  • Reactive arthritis (ReA) remains a significant clinical challenge with unclear pathogenesis.
  • The development of universally accepted diagnostic criteria for ReA is urgently needed.
  • Current research highlights similarities between ReA and experimental antigen-induced arthritis models.

Purpose of the Study:

  • To review recent advancements in understanding reactive arthritis.
  • To emphasize the critical need for standardized diagnostic criteria.
  • To discuss the role of molecular mechanisms and potential therapeutic interventions.

Main Methods:

  • Literature review of recent studies on reactive arthritis.
  • Analysis of research on antigen-induced arthritis models.

Related Experiment Videos

  • Evaluation of findings related to HLA-B27 and Chlamydia-triggered ReA.

    • Main Results:

    • No substantial progress in ReA pathogenesis or treatment understanding in the past year.
    • The lack of consensus on diagnostic criteria is a central issue.
    • Molecular mechanisms underlying HLA-B27-associated ReA pathogenesis remain elusive.
    • Antibiotics show no efficacy in established ReA, except possibly in Chlamydia-induced cases.

    Conclusions:

    • Standardized diagnostic criteria for reactive arthritis are essential.
    • Further research is needed to elucidate HLA-B27-associated pathogenesis.
    • Targeted antibiotic therapy may be beneficial for specific subtypes of ReA, such as Chlamydia-triggered cases.